Hepatitis C can be cured and even eradicated by new "revolutionary" treatments. However, at present exorbitant prices, Eastern European countries cannot afford the new treatments, while in western rich and developed countries (e.g. Germany and France) they are already available. Concerted efforts of governments, public health officials, and the community at large, are needed to negotiate agreements with pharmaceuticals companies to make the new treatments accessible and affordable. When science has demonstrated that hepatitis C can be cured, it would be unforgivable if millions of infected patients from eastern parts of the continent were denied access to new treatment on grounds of high prices and financial constraints.
Keywords: Access; Hepatitis C; Treatment.